Biopure Corporation

Biopure Corporation was a biotechnology company focused on developing blood substitute products. Their main project involved a synthetic product designed to mimic hemoglobin, the protein in red blood cells responsible for transporting oxygen. This innovation aimed to provide alternatives for blood transfusions, particularly in emergency situations or for patients with rare blood types. Founded in the late 1980s, Biopure gained attention for its research but faced challenges in regulatory approval and commercialization. Despite promising beginnings, the company eventually struggled financially and underwent significant changes, including mergers and acquisitions in the biotech industry.